Trial Profile
Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary) ; Atenolol; Valsartan
- Indications Hypertension; Stroke
- Focus Therapeutic Use
- Acronyms FAVOR
- 02 Apr 2015 New trial record